ORX489 Tablets Clinical Trials (2026): 1 Studies for Healthy Adult Male and Female Volunteers
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ORX489 Tablets clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Adult Male and Female Volunteers) and 212 total planned enrollment. 1 ORX489 Tablets clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07413666 (Jun 2027).
Where to Participate: All ORX489 Tablets Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting ORX489 Tabletstrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| NE | Celerion | Lincoln68502 | NCT07413666 | Map |
ORX489 Tablets clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ORX489 Tablets clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07413666 | A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years | P1 | Healthy Adult Male and Female Volunteers | 212 | Feb 2026 |
All ORX489 Tablets trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07413666 | A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years | P1 | recruiting | 212 | Centessa Pharmaceuticals (UK) Limited | Feb 2026 |
ORX489 Tablets clinical trials: frequently asked questions
- How many ORX489 Tablets clinical trials are there?
- 1 ORX489 Tablets clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ORX489 Tablets clinical trials recruiting in 2026?
- Yes — 1 ORX489 Tablets trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is ORX489 Tablets being studied for?
- ORX489 Tablets is being studied for Healthy Adult Male and Female Volunteers. The trials are grouped by indication on this page.
- What phase is ORX489 Tablets in?
- ORX489 Tablets clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ORX489 Tablets clinical trials?
- The lead sponsor across the most ORX489 Tablets trials is Centessa Pharmaceuticals (UK) Limited. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ORX489 Tabletsas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: